RXRX SEC Filings | SEC Document SEARCH
Back to Search
RECURSION PHARMACEUTICALS, INC. (RXRX)
Ticker: RXRX
CIK: 0001601830
87
Filings Found (Last 1 Year)
Filter Filings
All
4
2026. 10. 1.
Dar Zavain (CIK 0001852075)
Insider trading report
FORM 4
Open Filing
4
2026. 10. 1.
Li Dean Y (CIK 0001837016)
Insider trading report
FORM 4
Open Filing
8-K
2026. 9. 15.
RECURSION PHARMACEUTICALS, INC. (RXRX) (CIK 0001601830)
Current report
8-K
Open Filing
4
2026. 9. 15.
Taylor Ben R (CIK 0001712276)
Insider trading report
FORM 4
Open Filing
4
2026. 9. 8.
Khan Najat (CIK 0002020969)
Insider trading report
FORM 4
Open Filing
4
2026. 9. 1.
Borgeson Blake (CIK 0001856094)
Insider trading report
FORM 4
Open Filing
4
2026. 8. 17.
Khan Najat (CIK 0002020969)
Insider trading report
FORM 4
Open Filing
4
2026. 8. 17.
Hallett David (CIK 0002006495)
Insider trading report
FORM 4
Open Filing
4
2026. 8. 17.
Taylor Ben R (CIK 0001712276)
Insider trading report
FORM 4
Open Filing
4
2026. 8. 4.
Borgeson Blake (CIK 0001856094)
Insider trading report
FORM 4
Open Filing
10-Q
2026. 6. 30.
RECURSION PHARMACEUTICALS, INC. (RXRX) (CIK 0001601830)
Quarterly report
10-Q
Open Filing
8-K
2026. 8. 5.
RECURSION PHARMACEUTICALS, INC. (RXRX) (CIK 0001601830)
Current report
8-K
Open Filing
4
2026. 7. 7.
Borgeson Blake (CIK 0001856094)
Insider trading report
FORM 4
Open Filing
4
2026. 7. 1.
Dar Zavain (CIK 0001852075)
Insider trading report
FORM 4
Open Filing
4
2026. 7. 1.
Li Dean Y (CIK 0001837016)
Insider trading report
FORM 4
Open Filing
4
2026. 6. 17.
Borgeson Blake (CIK 0001856094)
Insider trading report
FORM 4
Open Filing
4
2026. 6. 17.
HERSHBERG ROBERT (CIK 0001274139)
Insider trading report
FORM 4
Open Filing
4
2026. 6. 17.
Michor Franziska (CIK 0002045159)
Insider trading report
FORM 4
Open Filing
4
2026. 6. 17.
Sun Elaine D (CIK 0001805339)
Insider trading report
FORM 4
Open Filing
4
2026. 6. 17.
Dar Zavain (CIK 0001852075)
Insider trading report
FORM 4
Open Filing
4
2026. 6. 17.
Li Dean Y (CIK 0001837016)
Insider trading report
FORM 4
Open Filing
4
2026. 6. 17.
Bumpus Namandje (CIK 0002060594)
Insider trading report
FORM 4
Open Filing
8-K
2026. 6. 17.
RECURSION PHARMACEUTICALS, INC. (RXRX) (CIK 0001601830)
Current report
8-K
Open Filing
4
2026. 6. 15.
Taylor Ben R (CIK 0001712276)
Insider trading report
FORM 4
Open Filing
4
2026. 6. 5.
Khan Najat (CIK 0002020969)
Insider trading report
FORM 4
Open Filing
4
2026. 6. 5.
Gibson Christopher (CIK 0001856369)
Insider trading report
FORM 4
Open Filing
4
2026. 6. 3.
Bumpus Namandje (CIK 0002060594)
Insider trading report
FORM 4
Open Filing
4
2026. 6. 2.
Borgeson Blake (CIK 0001856094)
Insider trading report
FORM 4
Open Filing
4
2026. 5. 22.
Gibson Christopher (CIK 0001856369)
Insider trading report
FORM 4
Open Filing
4
2026. 5. 15.
Khan Najat (CIK 0002020969)
Insider trading report
FORM 4
Open Filing
4
2026. 5. 15.
Hallett David (CIK 0002006495)
Insider trading report
FORM 4
Open Filing
4
2026. 5. 15.
Gibson Christopher (CIK 0001856369)
Insider trading report
FORM 4
Open Filing
4
2026. 5. 15.
Taylor Ben R (CIK 0001712276)
Insider trading report
FORM 4
Open Filing
4
2026. 5. 7.
Gibson Christopher (CIK 0001856369)
Insider trading report
FORM 4
Open Filing
4
2026. 5. 5.
Borgeson Blake (CIK 0001856094)
Insider trading report
FORM 4
Open Filing
10-Q
2026. 3. 31.
RECURSION PHARMACEUTICALS, INC. (RXRX) (CIK 0001601830)
Quarterly report
10-Q
Open Filing
8-K
2026. 5. 6.
RECURSION PHARMACEUTICALS, INC. (RXRX) (CIK 0001601830)
Current report
8-K
Open Filing
8-K
2026. 4. 28.
RECURSION PHARMACEUTICALS, INC. (RXRX) (CIK 0001601830)
Current report
8-K
Open Filing
4
2026. 4. 22.
Gibson Christopher (CIK 0001856369)
Insider trading report
FORM 4
Open Filing
4
2026. 4. 7.
Gibson Christopher (CIK 0001856369)
Insider trading report
FORM 4
Open Filing
4
2026. 4. 7.
Borgeson Blake (CIK 0001856094)
Insider trading report
FORM 4
Open Filing
4
2026. 4. 6.
Taylor Ben R (CIK 0001712276)
Insider trading report
FORM 4
Open Filing
4
2026. 4. 1.
Dar Zavain (CIK 0001852075)
Insider trading report
FORM 4
Open Filing
4
2026. 4. 1.
Li Dean Y (CIK 0001837016)
Insider trading report
FORM 4
Open Filing
8-K
2026. 3. 25.
RECURSION PHARMACEUTICALS, INC. (RXRX) (CIK 0001601830)
Current report
8-K
Open Filing
4
2026. 3. 23.
Gibson Christopher (CIK 0001856369)
Insider trading report
FORM 4
Open Filing
4
2026. 3. 16.
Taylor Ben R (CIK 0001712276)
Insider trading report
FORM 4
Open Filing
4
2026. 3. 9.
Gibson Christopher (CIK 0001856369)
Insider trading report
FORM 4
Open Filing
4
2026. 3. 9.
Khan Najat (CIK 0002020969)
Insider trading report
FORM 4
Open Filing
4
2026. 3. 3.
Borgeson Blake (CIK 0001856094)
Insider trading report
FORM 4
Open Filing
424B5
2026. 2. 25.
RECURSION PHARMACEUTICALS, INC. (RXRX) (CIK 0001601830)
Prospectus
424B5
Open Filing
10-K
2025. 12. 31.
RECURSION PHARMACEUTICALS, INC. (RXRX) (CIK 0001601830)
Annual report
10-K
Open Filing
8-K
2026. 2. 25.
RECURSION PHARMACEUTICALS, INC. (RXRX) (CIK 0001601830)
Current report
8-K
Open Filing
4
2026. 2. 17.
Hallett David (CIK 0002006495)
Insider trading report
FORM 4
Open Filing
4
2026. 2. 17.
Gibson Christopher (CIK 0001856369)
Insider trading report
FORM 4
Open Filing
4
2026. 2. 17.
Taylor Ben R (CIK 0001712276)
Insider trading report
FORM 4
Open Filing
4
2026. 2. 17.
Khan Najat (CIK 0002020969)
Insider trading report
FORM 4
Open Filing
4
2026. 2. 6.
Khan Najat (CIK 0002020969)
Insider trading report
FORM 4
Open Filing
4
2026. 2. 6.
Taylor Ben R (CIK 0001712276)
Insider trading report
FORM 4
Open Filing
4
2026. 2. 6.
Hallett David (CIK 0002006495)
Insider trading report
FORM 4
Open Filing
4
2026. 2. 4.
Gibson Christopher (CIK 0001856369)
Insider trading report
FORM 4
Open Filing
4
2026. 2. 3.
Borgeson Blake (CIK 0001856094)
Insider trading report
FORM 4
Open Filing
4
2026. 1. 20.
Gibson Christopher (CIK 0001856369)
Insider trading report
FORM 4
Open Filing
8-K
2026. 1. 12.
RECURSION PHARMACEUTICALS, INC. (RXRX) (CIK 0001601830)
Current report
8-K
Open Filing
4
2026. 1. 6.
Borgeson Blake (CIK 0001856094)
Insider trading report
FORM 4
Open Filing
4
2026. 1. 5.
Gibson Christopher (CIK 0001856369)
Insider trading report
FORM 4
Open Filing
4
2026. 1. 2.
Dar Zavain (CIK 0001852075)
Insider trading report
FORM 4
Open Filing
4
2026. 1. 2.
Li Dean Y (CIK 0001837016)
Insider trading report
FORM 4
Open Filing
4
2025. 12. 29.
Taylor Ben R (CIK 0001712276)
Insider trading report
FORM 4
Open Filing
4
2025. 12. 22.
Khan Najat (CIK 0002020969)
Insider trading report
FORM 4
Open Filing
4
2025. 12. 19.
Gibson Christopher (CIK 0001856369)
Insider trading report
FORM 4
Open Filing
4
2025. 12. 15.
Taylor Ben R (CIK 0001712276)
Insider trading report
FORM 4
Open Filing
8-K
2025. 12. 8.
RECURSION PHARMACEUTICALS, INC. (RXRX) (CIK 0001601830)
Current report
8-K
Open Filing
4
2025. 12. 4.
Gibson Christopher (CIK 0001856369)
Insider trading report
FORM 4
Open Filing
4
2025. 12. 2.
Borgeson Blake (CIK 0001856094)
Insider trading report
FORM 4
Open Filing
4
2025. 11. 25.
Taylor Ben R (CIK 0001712276)
Insider trading report
FORM 4
Open Filing
8-K
2025. 11. 26.
RECURSION PHARMACEUTICALS, INC. (RXRX) (CIK 0001601830)
Current report
8-K
Open Filing
4
2025. 11. 17.
Khan Najat (CIK 0002020969)
Insider trading report
FORM 4
Open Filing
4
2025. 11. 17.
Gibson Christopher (CIK 0001856369)
Insider trading report
FORM 4
Open Filing
4
2025. 11. 17.
Taylor Ben R (CIK 0001712276)
Insider trading report
FORM 4
Open Filing
4
2025. 11. 5.
Khan Najat (CIK 0002020969)
Insider trading report
FORM 4
Open Filing
4
2025. 11. 4.
Gibson Christopher (CIK 0001856369)
Insider trading report
FORM 4
Open Filing
10-Q
2025. 9. 30.
RECURSION PHARMACEUTICALS, INC. (RXRX) (CIK 0001601830)
Quarterly report
10-Q
Open Filing
8-K
2025. 11. 4.
RECURSION PHARMACEUTICALS, INC. (RXRX) (CIK 0001601830)
Current report
8-K
Open Filing
8-K
2025. 10. 29.
RECURSION PHARMACEUTICALS, INC. (RXRX) (CIK 0001601830)
Current report
8-K
Open Filing
4
2025. 10. 23.
Gibson Christopher (CIK 0001856369)
Insider trading report
FORM 4
Open Filing
4
2025. 10. 10.
Gibson Christopher (CIK 0001856369)
Insider trading report
FORM 4
Open Filing
Previous
Page 5 of 5
Next
